Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects

被引：0
|
作者：
Mark D. Harnett
James Shipley
Laura MacLean
Ute Schwiderski
Bobby W. Sandage
机构：
[1] Indevus Pharmaceuticals,
[2] Inc. (now Endo Pharmaceuticals,undefined
[3] Inc.),undefined
[4] Coronado Biosciences,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Body Surface Area; Overactive Bladder; Tolterodine; Immediate Release; Solifenacin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：133 / 141
页数：8
相关论文
共 50 条
  • [1] Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects
    Harnett, Mark D.
    Shipley, James
    MacLean, Laura
    Schwiderski, Ute
    Sandage, Bobby W., Jr.
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (02) : 133 - 141
  • [2] Safety and Efficacy of Once-Daily Trospium Chloride Extended-release in Male Patients With Overactive Bladder
    MacDiarmid, Scott A.
    Ellsworth, Pamela I.
    Ginsberg, David A.
    Oefelein, Michael G.
    Sussman, David O.
    [J]. UROLOGY, 2011, 77 (01) : 24 - 29
  • [3] Once-Daily Trospium Chloride 60 mg Extended-Release Provides Effective, Long-Term Relief of Overactive Bladder Syndrome Symptoms
    Zinner, Norman R.
    Dmochowski, Roger R.
    Staskin, David R.
    Siami, Paul F.
    Sand, Peter K.
    Oefelein, Michael G.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) : 1214 - 1219
  • [4] Pharmacokinetics of Once-Daily Trospium Chloride 60 mg Extended Release and Twice-Daily Trospium Chloride 20 mg in Healthy Adults
    Silver, Nova
    Sandage, Bobby
    Sabounjian, LuAnn
    Schwiderski, Ute
    Shipley, James
    Harnett, Mark
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (02): : 143 - 150
  • [5] Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome
    Sand, Peter K.
    Johnson, Theodore M., II
    Rovner, Eric S.
    Ellsworth, Pamela I.
    Oefelein, Michael G.
    Staskin, David R.
    [J]. BJU INTERNATIONAL, 2011, 107 (04) : 612 - 620
  • [6] Trospium Chloride Once-Daily Extended Release is Efficacious and Tolerated in Elderly Subjects (Aged ≥ 75 Years) With Overactive Bladder Syndrome Editorial Comment
    Griebling, Tomas L.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (03): : 991 - 992
  • [7] Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?
    Wyndaele, JJ
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (04): : 184 - 185
  • [8] Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?
    Jean Jacques Wyndaele
    [J]. Nature Clinical Practice Urology, 2006, 3 : 184 - 185
  • [9] Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: A review
    Rovner, ES
    Wein, AJ
    [J]. EUROPEAN UROLOGY, 2002, 41 (01) : 6 - 14
  • [10] Trospium chloride once-daily extended release is effective and well tolerated in elderly patients (aged 75 years and over) with overactive bladder (OAB)
    Sand, P.
    Dmochowski, R.
    Rovner, E.
    Sandage, Jr B.
    Harnett, M.
    Ellsworth, P.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S57 - S58
12345